DreamCIS Inc (223250) - Total Liabilities
Based on the latest financial reports, DreamCIS Inc (223250) has total liabilities worth ₩60.03 Billion KRW (≈ $40.68 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 223250 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
DreamCIS Inc - Total Liabilities Trend (2017–2024)
This chart illustrates how DreamCIS Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see DreamCIS Inc total assets.
DreamCIS Inc Competitors by Total Liabilities
The table below lists competitors of DreamCIS Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
GAMEVIL Inc
KQ:063080
|
Korea | ₩266.43 Billion |
|
Wisekey International Holding AG
SW:WIHN
|
Switzerland | CHF53.44 Million |
|
Chang Type Industrial Co Ltd
TW:1541
|
Taiwan | NT$1.26 Billion |
|
Skillsoft Corp.
NYSE:SKIL
|
USA | $925.83 Million |
|
Yesil Gayrimenkul Yatirim Ortakligi AS
IS:YGYO
|
Turkey | TL7.54 Billion |
|
Eloxx Pharmaceuticals, Inc.
NASDAQ:ELOX
|
USA | $16.97 Million |
|
Bridgford Foods Corporation
NASDAQ:BRID
|
USA | $33.26 Million |
|
Columbus
WAR:CLC
|
Poland | zł217.79 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down DreamCIS Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See DreamCIS Inc (223250) balance sheet quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.72 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how DreamCIS Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for DreamCIS Inc (2017–2024)
The table below shows the annual total liabilities of DreamCIS Inc from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩50.58 Billion ≈ $34.28 Million |
+59.57% |
| 2023-12-31 | ₩31.70 Billion ≈ $21.48 Million |
+9.26% |
| 2022-12-31 | ₩29.01 Billion ≈ $19.66 Million |
+54.92% |
| 2021-12-31 | ₩18.73 Billion ≈ $12.69 Million |
+54.34% |
| 2020-12-31 | ₩12.13 Billion ≈ $8.22 Million |
-14.99% |
| 2019-12-31 | ₩14.27 Billion ≈ $9.67 Million |
+28.92% |
| 2018-12-31 | ₩11.07 Billion ≈ $7.50 Million |
+3.25% |
| 2017-12-31 | ₩10.72 Billion ≈ $7.27 Million |
-- |
About DreamCIS Inc
DreamCIS, Inc. operates as a clinical research organization in South Korea. It offers clinical development services; biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and regulatory consulting services. The company was founded in 2000 and is headqua… Read more